Page last updated: 2024-09-03

garenoxacin and nalidixic acid

garenoxacin has been researched along with nalidixic acid in 3 studies

Compound Research Comparison

Studies
(garenoxacin)
Trials
(garenoxacin)
Recent Studies (post-2010)
(garenoxacin)
Studies
(nalidixic acid)
Trials
(nalidixic acid)
Recent Studies (post-2010) (nalidixic acid)
19519463,24687340

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W1
Aubry, A; Cambau, E; Jarlier, V; Matrat, S1
Blaskovich, MAT; Pham, TDM; Ziora, ZM1

Reviews

1 review(s) available for garenoxacin and nalidixic acid

ArticleYear
Quinolone antibiotics.
    MedChemComm, 2019, Oct-01, Volume: 10, Issue:10

    Topics:

2019

Other Studies

2 other study(ies) available for garenoxacin and nalidixic acid

ArticleYear
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors

2007
Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae

2008